You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Topic 373: alteRNAting-seq

    SBC: ELECTRONIC BIOSCIENCES, INC.            Topic: NCI

    During this Phase I SBIR project, Electronic BioSicences (EBS) will develop a direct, long-read, RNA strand sequencing methodology that is capable of sequencing both canonical and specific modified nucleotides with high-accuracy. This will result in the development of technology wherein a single-stranded RNA (ssRNA) molecule is translocated through a nanopore reader using an applied voltage bias a ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Topic 372: Development and Validation of Non- Mouse Reagents to Enable Preclinical Development of Novel Therapeutics

    SBC: AVANTGEN INC            Topic: NCI

    There is an increasing appreciation that dogs with naturally occurring cancers may be a better model system for evaluating cancer therapeutics than the traditional mouse model systems. However, use of dogs for evaluating the emerging class of immunotherapeutics for oncology is limited by the availability of suitable reagents to mentor the response of the canine immune system. The majority of reage ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. Topic 372: Development of the Fully Humanized 9-in-9-out Rat Drug Metabolism-CYP450 Model, Using the Active Genetic: Gene Drive Technology

    SBC: SYNBAL INC            Topic: NCI

    In this Fast track SBIR grant we aim, by the end of Phase II, to prepare and commercialize a fully humanized rat with Knock-out of many rat drug metabolism related CYP450's (9-in-9-out Rat Drug Metabolism-CYP450 Model) and Knock-in of the human counterpart. IN PHASE I we will develop an Active Genes: Gene Drive (AG:GD) rat - a rat with a properly configured Cas9 to power Active Genetics (AG); AND, ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  4. Development of an oral drug targeting SUMOylation

    SBC: SUVALENT THERAPEUTICS INC.            Topic: 102

    c Mycand KRas dependent cancerssuch as colorectal cancerrepresent major unmet medical needs that currently lack targeted therapyRecent scientific advances revealed that theseundruggableoncogenes critically depend on post translational modification with the small ubiquitin like modifierSUMOfamily of proteinsand inhibiting SUMOylation inhibits c Myc and KRasFurthermoreSUMOylation inhibition can acti ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  5. Developing an efficient E-cigarette aerosol generation and exposure system for rodent models with aerosol characteristics equivalent to those inhaled by E-cigarette users

    SBC: AUTOMATE SCIENTIFIC, INC.            Topic: NIDA

    Abstract E cigaretteE ciguse has rapidly proliferated worldwideIt is speculated that E cig use may exceed conventional cigarette use withinyearsCigarette smoking is the leading preventable cause of death and disabilityAs E cigs are a relatively new productstudies are needed to determine their long term detrimental effectssome of which may be similar to the long term detrimental effects of nicotine ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Tissue Oxygen Monitoring in Peripheral Vascular Disease

    SBC: PROFUSA, INC.            Topic: NHLBI

    DESCRIPTIONprovided by applicantThe goal of this Fast Track SBIR is to demonstrate the functionality of PROFUSAandapos s novel injectable tissue oxygen monitors in patients with peripheral arterial diseasePADand to determine the its ability to detect restenosis in critical limb ischemiaCLIPAD is a manifestation of systemic atherosclerosis that affectsmillion people in the U Swith prevalence increa ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Scriptmate: A patient-centered mobile system for geriatric prescription medication management

    SBC: DIMAGI, INC.            Topic: NIA

    PROJECT SUMMARY Elderly patients are the largest consumers of prescription and non prescription medications and have been reported to account for $million in treatment costs for medication errors likely due to altered pharmacokineticspolypharmacydecline in cognitionand lower health literacyAs a result of this confluence of issues that affect the aging populationmedication management tools designed ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Smokescreen Translational (TL) Analysis Platform

    SBC: BIOREALM, LLC            Topic: 500

    Project Summary Tobacco-attributable disease remains the largest potentially modifiable cause of mortality. Strategies to reduce smoking prevalence include developing more effective smoking cessation treatments. Nicotine metabolism and dependence are predictors of smoking behaviors, including response to smoking cessation treatments. The goal of this Phase II project is to develop prediction mode ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Use of DNATrax and high fidelity computational methods to model transport of contaminants in urban environments

    SBC: SAFETRACES INC            Topic: NIEHS

    PROJECT SUMMARY ! The abundance of airborne micron sized pollutant correlates with the prevalence and severity of respiratory diseaseswhich represents therd leading cause of death in the United States and have an economical cost of tens of billions of dollars per yearGrowing concerns on the possibility of terrorist attacks have motivated efforts in preparing for and responding to airborne releases ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care

    SBC: C4 Innovations, LLC            Topic: NIMH

    PROJECT SUMMARY In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) has partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care. The product builds on the findings of the Recovery After an Initial ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government